Our team of forward-looking, business-minded professionals brings an extensive and varied background to implement research, development, manufacturing, marketing, and distribution of “best-in-class” wellness products and services.


The Company manages a leading edge portfolio of products and has developed precise marketing strategies to bring regenerative health to people while contributing to the prosperity of brand partners and engaged practitioners.

The Principals of our executive team are highly regarded in their respective areas of expertise. Their diverse range of talents, skills, and resources provide BioRegenx with a distinct market advantage.

Our organization values collaboration with an emphasis on scalability and affecting the wellness of customers and patients. These notions benefit from the wealth of knowledge among all subsidiaries and departments.

William Resides
Bill is the CEO of the Company. An experienced sales executive and passionate entrepreneur, Bill is the Co-founder and Chief Executive Officer of NuLife where he leads a global team of Brand Partners on a mission of redefining health utilizing the latest in technologies and top of class products in the health and wellness sector. He has served in that role since January 2, 2019. From October 2012 to January 1, 2019, Bill has been a managing member of NuLife Ventures LLC. From March 2016 to present, Bill has been a managing member of Resides Enterprises, LLC., a management consulting company. In addition, Bill has served as Vice President of Business Development for Loop Media Inc, a public company, as well as the Vice President of Business Development for Crypto Insiders LLC, and Money Clip 360 Inc., developing innovation agendas and digital strategies to move their portfolio of products and services into online “Hy-bred Direct Sales” model. Before NuLife,, Bill was in Chief Executive roles at AllTech Systems LLC, Allwired Technologies Inc. and Audio Visions Inc., throughout the ’90s until 2011. From 1986 to 1988, Mr. Resides attended Carson Newman College.
Robert M Long
Robert M.Long
Bob is the Chairman of the Board and Chief Operations Officer of the Company. Since June 2014, Bob has been the Chief Executive Officer and Manager of MVHS, a research and development and nutraceutical company. He is the co-inventor of Endocalyx™ on patents in multiple countries. Since October 2013, Bob has been the Chief Executive Officer and Manager of GlycoCheck™, a research and development, medical device company specializing in the research of endothelial glycocalyx. Since May 2015, Bob has been Chief Executive Officer and Manager of My Body Rx™, a research and development company. Since November 2008, Bob has been the Managing Partner of RNL Lone Peak Holdings. Bob attended Brigham Young University from 1972-1973. He was Managing Director for Northwestern Mutual from 1980 to 2004. Served as a member of a variety of Northwestern Mutual company committees, including compliance, claims, disability, products, life products, annuities, and compensation marketing. In 2003, served as the President of the Managing Directors Association representing 355 managing directors and the interest of their agents, representing about 45 percent of the company’s sales force. Spoke regularly at the Marriott School of Business at Brigham Young University for accounting and business management classes. Topics included risk management, life insurance, annuities, and investments. Also spoke on recruiting and training effective salespeople. Bob sold his insurance and financial planning group in 2004. He then became Vice President of Sales of Vantage Controls, an early-market leader in lighting control home automation. In 2006, Bob was involved in the negotiations and sale of Vantage Controls to Legrand, the largest electrical device company in the world.
Hans Vink
Hans Vink, PhD.
Chief Science Officer & Director
Dr. Vink is the Chief Science Officer for the Company and MVHS. Dr. Vink is a pioneer in the study of the endothelial glycocalyx. He is one of the first researchers to study the glycocalyx when he focused his expertise on medical imaging. As a result, Dr. Vink and his team were one of the first research groups to capture realistic images of the glycocalyx and focus on its significance. He had been studying the microvascular system since the 1980s. It wasn’t until the mid-1990s that technology advancements enabled peering deep inside the capillaries to take pictures. The discovery of a very thick glycocalyx, and development of new techniques to take the early pictures, has led to ongoing research to determine how a compromised glycocalyx is linked to diseases and conditions. In September 1989, Dr. Vink obtained a M.Sc. Physics from the University of Amsterdam. In June 1994, Dr. Vink obtained a Ph.D. Medical Physics from the University of Amsterdam. He continued his research as a postdoctoral fellow at the University of Virginia and returned to Amsterdam in 1997 to continue his work. He was awarded a Research Fellowship from the Royal Netherlands Academy of Arts and Sciences for his study of the glycocalyx from 2000 through 2005. In 2005 he became an Established Investigator of the Netherlands Heart Foundation. From 2006 to 2021, Dr. Vink was an Associate Professor at Maastricht University. From 2010 to present, Dr. Vink has been Chief Science Officer and Director of GlycoCheck™ where he conducts research and development relating to glycocalyx science. He is the co-inventor of the GlycoCheck™ methods patent and Endocalyx™ on patents in multiple countries. From 2014 to present, Dr Vink has been Chief Science Officer of MVHS where he conducts validation, testing and science relating to the development of the Endocalyx™ supplement.
Joseph Bird MD
Joseph S. Bird, M.D.
Chief Medical Officer
Dr. Bird is the Chief Medical Officer for the Company and NuLife. From 1996 to present, Dr. Bird has practiced medicine at the Fertility Center LLC, Obstetrics and Gynecology Foundation and the University of Tennessee at Chattanooga, Department of Obstetrics and Gynecology. Dr. Bird obtained a Nursing A.S. from Southern Collegedale, TN in 1983 and a B.A. in Chemistry in 1986 from the University of Tennessee. Dr. Bird earned his Doctor of Medicine from East Tennessee State University – James H. Quillen College of Medicine in 1990. Dr. Bird holds medical licenses in Tennessee since July 1991 and Kentucky since December 1993. Dr. Bird’s first intended specialty was retinal surgery, but a rotation with a reproductive endocrinologist while attending East Tennessee State University’s James H. Quillen College of Medicine changed his mind. His four-year residency began in 1990 in the Department of Obstetrics and Gynecology within the Chattanooga Unit of the University of Tennessee College of Medicine. A two-year fellowship followed in the Reproductive Endocrinology and Infertility Division at the University of Louisville School of Medicine’s Department of Obstetrics and Gynecology.”
Bob Doran
Robert Doran
Executive Vice President & Director
Bob has been the CMO and Co-Founder of NuLife since December 2018 to December 2019 and the Executive Vice President and Co-Founder of NuLife since January 2020. From March 1995 to present, Bob has been the Co-Founder of LifePower, Inc., a management company. From June 1999 to present, Bob has been the Co-Founder of Energy Network, LLC, a marketing consulting company From January 2020 to present, Mr. Doran has been the Co-Founder of Traction X39 LLC, a real estate holdings company. Mr. Doran is a traditional business guy that started in Cable TV at age 14… then graduated into Real Estate sales and Investing. In 1999, after a few years of Mentorship, he and his wife launched their own Magazine, House & Home Magazine, that they grew to over 500,000 readers, exiting in 2012 with a sale to a large media company. Bob has 28 years in Direct Sales, on the Ownership side as well as the Master Distributor and Rep sides. He received this first direct sales experience with Rexall Showcase International and his first direct sales ownership experience was with AmeriStar, a company that had an agreement with DISH Network. Bob helped grow a customer base of 250,000 in a third-party Direct Sales energy company before helping the company to a successful exit with a valuation of over 100 million dollars.
Gary Hennerberg
Gary Hennerberg
Chief Marketing Officer & Director
Gary is the Chief Marketing Officer and is Secretary for BioRegenx. Since May 1, 2016 to present, Gary was the Chief Marketing Officer for MVHS. From 2012 to April 30, 2016, Gary was a marketing consultant for MVHS. In 1992, Gary founded Hennerberg Group, Inc., an independent marketing consulting entity providing consulting analytics and sales copywriting serves to over 100 clients nationwide including AAA, CitiFinancial, Collin Street Bakery, Dow Chemical, Sprint, and dozens more. Gary’s process begins with analysis and interpretation of data and numbers. He develops custom formulas, analyses and models based on 30-plus years of working in traditional direct response marketing. These models are foundational for every organization to calculate long-term value, allowable marketing costs, and budget forecasts. He is considered a full-stack marketer with experience in a broad array of marketing responsibilities. Gary is the author of “Crack the Customer Mind Code / Seven Pathways from Head to Heart to YES!” (Morgan James Publishing) 2016; Author of “Direct Marketing Quantified: The Knowledge is in the Numbers” (Target Marketing Publishing) 2005. Columnist and webinar presenter for Target Marketing Magazine and Today @ Target Marketing 1993 – 2016, and a speaker at numerous events. He has taught copywriting courses for American Writers and Artists since 2004. Prior to 1992, he was Vice President of U.S. Communications Marketing Agency, Vice President of Direct Marketing for CMF&Z, a Young and Rubicam Advertising Agency, and on the client-side Gary has worked as a Product Manager and Marketing Manager. Gary obtained a B.A. Communications from Fort Hays State University in 1978.
Jody Walker
SEC Attorney/Legal Counsel & Director
Jody is a Director for the Company and also acts as its corporate and securities counsel. From 1989 to present, Jody has been in private practice as a securities and corporate attorney. Her practice focuses primarily on regulatory compliance, mergers and acquisitions, public and private offerings with debt and equity securities, blue sky filings and general corporate matters. Jody earned her Juris Doctorate from Hamline University in 1985 focusing on securities and taxation. She earned a Bachelor of Individualized Studies majoring in international business, french and government from the University of Minnesota in 1982.
Suzanne Bird
Suzanne Bird
Suzanne is the wife of Joseph S. Bird, Jr., M.D., co-founder of the Company and NuLife. Suzanne received her B.S. in Computer Science, in December 1985 from Southern Adventist University, Collegedale, Tennessee. She wrote and supported accounting software for the rental/retail industry from 1986 to 1991. From 2006 to the present, she is the Financial Administrator of the Fertility Center with offices located in Chattanooga and Knoxville, Tennessee.
Dan Cortes
Dan Cortes
Chief Financial Officer
Dan has 25+ years of financial management experience in various capacities. He started his career with KPMG in their Phoenix Office. After spending 9 years at KPMG, Dan moved into financial management positions in private industry. Dan has a broad range of experience in finance, operations, accounting, international business and taxation and has worked in the direct sales, wholesale, manufacturing and real estate industries. Dan has held various CFO positions including with muti-million-dollar, multinational Direct Company. He has experience with developing and implementing accounting and tax systems for startups to more mature companies, staff development, reporting, insurance and claims, operational procedures, legal support and international operations. He is a CPA and a member of the AICPA and the Arizona Society of CPAs. Dan graduated with honors from Arizona State University with a B.S. in Accounting.